Government Affairs
Refine Search
Pharmaceutical
US Senator Cory Booker (Democrat, New Jersey) on Friday announced legislation to systemically change the way prescription drugs are priced in order to reduce drug costs for Americans and increase access to the medications they need, with Senators Bernie Sanders (Independent, Vermont) and Kamala Harris (Democrat, California) joining him as original co-sponsors. 18 November 2019
Pharmaceutical
With a December general election looming in the UK, the British pharmaceutical industry has outlined its policy priorities, calling on political parties to support UK science and research. 14 November 2019
Pharmaceutical
The list price of drugs prescribed on the UK’s National Health Service (NHS) has been published for the year 2018-19. 14 November 2019
Biotechnology
The US Department of Health and Human Services (HHS) has filed a patent infringement lawsuit against Californian biotech major Gilead Sciences. 7 November 2019
Pharmaceutical
The US Food and Drug Administration has published a draft document which outlines its methodology for conducting ongoing post-marketing safety surveillance. 7 November 2019
Pharmaceutical
The Russian government may consider the possibility of beginning public procurements of prescription drugs with their further provision to local population, according to recent statements, made by representatives of the Ministry of Health, reports The Pharma Letter’s local correspondent 5 November 2019
Pharmaceutical
Changes, confusion and costs have characterized a drug labeling experiment in Russia since it began at the beginning of 2017, so far as many manufacturers are concerned. 4 November 2019
Pharmaceutical
US President Donald Trump on Friday announced his intention to nominate Stephen Hahn to be the next Commissioner of the US Food and Drug Administration. 2 November 2019
Pharmaceutical
Hungarian trade group the Association of Innovative Pharmaceutical Manufacturers (AIPM) has published the results of a survey of pharma leaders to show the need to invest in new medicines. 28 October 2019
Pharmaceutical
The US Department of Health and Human Services on Friday announced approximately $2.27 billion in Ryan White HIV/AIDS Program grants were awarded to cities, counties, states, and local community-based organizations in fiscal year (FY) 2019. 26 October 2019
Pharmaceutical
When Brexit will happen, and whether it will involve the UK leaving with or without a deal, is not something that anyone can tell companies, but the government is at least making efforts to help them prepare for every eventuality. 25 October 2019
Pharmaceutical
Medicines Australia has today welcomed the publication of the Department of Health’s annual report, showing net expenditure on the Pharmaceutical Benefits Scheme has risen by over 4% in 2018-19 to A$9.8 billion ($6.71 billion). 25 October 2019
Pharmaceutical
The US medicines regulator has provided an update on its work to address the country’s ongoing opioid epidemic, leveraging new powers granted in 2018 under the SUPPORT Act. 25 October 2019
Pharmaceutical
Within Europe agreements are regularly made regarding changes to information on medicinal products. 21 October 2019
Pharmaceutical
An important Congressional committee has approved House Speaker Nancy Pelosi’s pharmaceutical pricing bill, leading the way to further debate and an eventual vote in the US House of Representatives. 18 October 2019
Biotechnology
The USA’s Biotechnology Innovation Organization’s (BIO), after the Congressional Budget Office (CBO) released an analysis confirming that Bill HR 3 will lead to fewer new medicines for patients, issued its own warning. 18 October 2019
Pharmaceutical
David Baker, a business consultant at J+D Forecasting, provides an Expert View on potential implications for the pharmaceutical industry of UK Labour Party leader Jeremy Corbyn's recently-announced proposals. 17 October 2019
Biotechnology
“It’s great to hear the government recognizes the enormous contribution of the UK life sciences sector to the wider UK economy, which was highlighted at numerous points in today’s Queen’s speech,” Steve Bates, chief executive of the UK’s BioIndustry Association (BIA) in response to the opening of Parliament speech by the Monarch on behalf of the Prime Minister Boris Johnson’s government yesterday. 14 October 2019
Pharmaceutical
The Irish Pharmaceutical Healthcare Association (IPHA) says that the country’s government must make sure that Brexit does not cause access to medicines to fall further relative to other European countries. 14 October 2019
Pharmaceutical
China is currently the second largest pharmaceutical market in the world and is aiming to be a major innovator as well, as part of its ‘Made in China 2025’ program. 14 October 2019
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze